Loss of inhibitory insulin receptor substrate-1 phosphorylation: An early event in endometrial hyperplasia and progression to carcinoma

Cell Cycle

Volumn 9, Issue 14, 2010, Pages 2698-2699

  McCampbell, Adrienne S ^a   Broaddus, Russell R ^a   Walker, Cheryl L ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAMARTIN; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; SERINE; TUBERIN;

CANCER GROWTH; CELL GROWTH; EDITORIAL; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; NONHUMAN; PROTEIN DEGRADATION; PROTEIN PHOSPHORYLATION;

EID: 77956860984     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.14.12618     Document Type: Editorial

References (9)

1. Foster KG, et al. J Biol Chem 2010; 285:14071-7.
2. Boura-Halfon S, et al. Am J Physiol Endocrinol Metab 2009; 296:E581-91.
3. Becker S, et al. Arch Physiol Biochem 2009; 115:86-96.
4. Tzatsos A, et al. Mol Cell Biol 2006; 26:63-76.
5. Lu KH, et al. Clin Cancer Res 2008; 14:2543-50.
6. McCampbell AS, et al. Clin Cancer Res 2006; 12:6373-8.
7. Kurman RJ, et al. Cancer 1985; 56:403-12.
8. McCampbell AS, et al. Cancer Prev Res (Phila Pa); 3:290-300.
9. Cook JD, et al. Curr Mol Med 2004; 4:813-24.